SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+11.6%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$359M
AUM Growth
+$359M
(+15%)
Cap. Flow
+$57.2M
Cap. Flow
% of AUM
15.94%
Top 10 Holdings %
Top 10 Hldgs %
73.89%
Holding
44
New
12
Increased
4
Reduced
14
Closed
8
Top Buys
| 1 |
Nkarta
NKTX
|
$61.2M |
| 2 |
CureVac
CVAC
|
$17.2M |
| 3 |
Cogent Biosciences
COGT
|
$13.3M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$6.66M |
| 5 |
Equillium
EQ
|
$6.2M |
Top Sells
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$20.5M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$7.6M |
| 3 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$6.71M |
| 4 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$6.01M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$5.28M |
Sector Composition
| 1 | Healthcare | 98.1% |
